{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T21:57:16Z","timestamp":1782597436077,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40122-025-00767-x","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:47:36Z","timestamp":1754920056000},"page":"1611-1627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China: A Retrospective, Database, Multicenter Study (ReTARdant) Protocol"],"prefix":"10.1007","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct06546202","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Qi","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bifa","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"767_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanp\u00e4\u00e4 M, et al. A new definition of neuropathic pain. Pain. 2011;152:2204\u20135.","journal-title":"Pain"},{"key":"767_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.","journal-title":"Nat Rev Dis Primers"},{"key":"767_CR3","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.12998\/wjcc.v9.i9.2100","volume":"9","author":"H Xiao","year":"2021","unstructured":"Xiao H, Ma K, Huang D, et al. Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain. World J Clin Cases. 2021;9:2100\u20139.","journal-title":"World J Clin Cases"},{"key":"767_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"NB Finnerup","year":"2021","unstructured":"Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021;101:259\u2013301.","journal-title":"Physiol Rev"},{"key":"767_CR5","first-page":"10663","volume":"24","author":"K-S Wei","year":"2020","unstructured":"Wei K-S, Gu M-Z, Zhu J-W, Hu H-C, Yin L-P. Current views of diabetic peripheral neuropathic pain comorbid depression\u2014a review. Eur Rev Med Pharmacol Sci. 2020;24:10663\u201370.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"767_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110602","volume":"198","author":"C Li","year":"2023","unstructured":"Li C, Wang W, Ji Q, et al. Prevalence of painful diabetic peripheral neuropathy in type\u00a02 diabetes mellitus and diabetic peripheral neuropathy: a nationwide cross-sectional study in mainland China. Diabetes Res Clin Pract. 2023;198:110602.","journal-title":"Diabetes Res Clin Pract"},{"key":"767_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12885-019-5302-4","volume":"19","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis A, Cheng HL, Lopez V, et al. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer. 2019;19:132.","journal-title":"BMC Cancer"},{"key":"767_CR8","first-page":"2959","volume":"29","author":"Y-J Wang","year":"2021","unstructured":"Wang Y-J, Chan Y-N, Jheng Y-W, et al. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study. Support Care Cancer. 2021;29:2959\u201371.","journal-title":"Support Care Cancer"},{"key":"767_CR9","doi-asserted-by":"publisher","first-page":"1327318","DOI":"10.3389\/fonc.2024.1327318","volume":"14","author":"S Lixian","year":"2024","unstructured":"Lixian S, Xiaoqian Y, Luyan G, et al. Risk factors of paclitaxel-induced peripheral neuropathy in patients with breast cancer: a prospective cohort study. Front Oncol. 2024;14:1327318.","journal-title":"Front Oncol"},{"key":"767_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijgo.13137","volume":"149","author":"L Jin","year":"2020","unstructured":"Jin L, Zhang Y, Yang W. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer. Intl J Gynecol Obste. 2020;149:303\u20138.","journal-title":"Intl J Gynecol Obste"},{"key":"767_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1212\/WNL.0000000000013038","volume":"98","author":"R Price","year":"2022","unstructured":"Price R, Smith D, Franklin G, et al. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee. Neurology. 2022;98:31\u201343.","journal-title":"Neurology"},{"key":"767_CR12","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan B, Margulies A, Cardoso F, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31:1306\u201319.","journal-title":"Ann Oncol"},{"key":"767_CR13","first-page":"484","volume":"20","author":"Z Cheng","year":"2024","unstructured":"Cheng Z, Lyu Y, Liu X. A Chinese guideline for the diagnosis and treatment of neuropathic pain (2024 edition). Chin J Painol. 2024;20:484\u2013508.","journal-title":"Chin J Painol"},{"key":"767_CR14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s40122-021-00281-w","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang S, Pan L, et al. Painful diabetic peripheral neuropathy study of Chinese outpatients (PDNSCOPE): a multicentre cross-sectional registry study of clinical characteristics and treatment in mainland China. Pain Ther. 2021;10:1355\u201373.","journal-title":"Pain Ther"},{"key":"767_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.813210","volume":"12","author":"J Lian","year":"2022","unstructured":"Lian J, Wang H, Cui R, Zhang C, Fu J. Status of analgesic drugs and quality of life results for diabetic peripheral neuropathy in China. Front Endocrinol. 2022;12: 813210.","journal-title":"Front Endocrinol"},{"key":"767_CR16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EML Smith","year":"2013","unstructured":"Smith EML, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309:1359.","journal-title":"JAMA"},{"key":"767_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242467","volume":"16","author":"Y-C Yeh","year":"2021","unstructured":"Yeh Y-C, Cappelleri JC, Marston XL, Shelbaya A. Effects of dose titration on adherence and treatment duration of pregabalin among patients with neuropathic pain: a MarketScan database study. PLoS\u00a0One. 2021;16:e0242467.","journal-title":"PLoS\u00a0One"},{"key":"767_CR18","first-page":"293","volume":"11","author":"C White","year":"2018","unstructured":"White C, Kwong WJ, Armstrong H, Behling M, Niemira J, Lang K. Analysis of real-world dosing patterns for the 3 FDA-approved medications in the treatment of fibromyalgia. Am Health Drug Benefits. 2018;11:293\u2013301.","journal-title":"Am Health Drug Benefits"},{"key":"767_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.diabres.2013.12.003","volume":"103","author":"SS Kim","year":"2014","unstructured":"Kim SS, Won JC, Kwon HS, et al. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type\u00a02 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract. 2014;103:522\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"767_CR20","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1097\/j.pain.0000000000001034","volume":"158","author":"J Raputova","year":"2017","unstructured":"Raputova J, Srotova I, Vlckova E, et al. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study. Pain. 2017;158:2340\u201353.","journal-title":"Pain"},{"key":"767_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.637593","volume":"12","author":"M Selvy","year":"2021","unstructured":"Selvy M, Kerckhove N, Pereira B, et al. Prevalence of chemotherapy-induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: a single center cross-sectional study. Front Pharmacol. 2021;12:637593.","journal-title":"Front Pharmacol"},{"key":"767_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261473","volume":"16","author":"S Hiramoto","year":"2021","unstructured":"Hiramoto S, Asano H, Miyamoto T, Takegami M, Kawabata A. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: a retrospective study in Japan. PLoS\u00a0One. 2021;16:e0261473.","journal-title":"PLoS\u00a0One"},{"key":"767_CR23","first-page":"1765","volume":"30","author":"S Yokoyama","year":"2022","unstructured":"Yokoyama S, Nakagawa C, Hosomi K. Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study. Support Care Cancer. 2022;30:1765\u201373.","journal-title":"Support Care Cancer"},{"key":"767_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1055\/s-0036-1584950","volume":"36","author":"J Gierthm\u00fchlen","year":"2016","unstructured":"Gierthm\u00fchlen J, Baron R. Neuropathic pain. Semin Neurol. 2016;36:462\u20138.","journal-title":"Semin Neurol"},{"key":"767_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40122-020-00210-3","volume":"10","author":"A Liampas","year":"2021","unstructured":"Liampas A, Rekatsina M, Vadalouca A, Paladini A, Varrassi G, Zis P. Pharmacological management of painful peripheral neuropathies: a systematic review. Pain Ther. 2021;10:55\u201368.","journal-title":"Pain Ther"},{"key":"767_CR26","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.12659\/MSM.912273","volume":"24","author":"H Xiao","year":"2018","unstructured":"Xiao H, Liu H, Liu J, et al. Pain prevalence and pain management in a Chinese hospital. Med Sci Monit. 2018;24:7809\u201319.","journal-title":"Med Sci Monit"},{"key":"767_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1533-2500.2012.00537.x","volume":"12","author":"P Sun","year":"2012","unstructured":"Sun P, Zhao Y, Zhao Z, Bernauer M, Watson P. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain. Pain Pract. 2012;12:641\u20138.","journal-title":"Pain Pract"},{"key":"767_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/aas.12697","volume":"60","author":"L Timmerman","year":"2016","unstructured":"Timmerman L, Stronks DL, Groeneweg JG, Huygen FJ. Prevalence and determinants of medication non-adherence in chronic pain patients: a systematic review. Acta Anaesthesiol Scand. 2016;60:416\u201331.","journal-title":"Acta Anaesthesiol Scand"},{"key":"767_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5935\/1806-0013.20160060","volume":"17","author":"MGM Cardoso","year":"2016","unstructured":"Cardoso MGM, Weinstock JG, Sard\u00e1 J\u00fanior JJ. Adhesion to neuropathic pain treatment. Rev Dor. 2016;17:107\u20139.","journal-title":"Rev Dor"},{"key":"767_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5993\/AJHB.47.1.4","volume":"47","author":"X Zhao","year":"2023","unstructured":"Zhao X, Xu R, Wang Y, et al. Adherence to analgesic drugs and its associated factors among patients with cancer pain: a crosssectional study in China. Am J Health Behav. 2023;47:30\u20139.","journal-title":"Am J Health Behav"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-025-00767-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T17:12:57Z","timestamp":1759252377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-025-00767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1007\/s40122-025-00767-x","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Daiichi Sankyo (China). All authors (Qi Pan, Xiaoyu Zhai, Haining Wang, Jianling Du, Yanxia Shi, Xuefeng Yu, Sunjie Yan, Xiaohong Wu, Hui-hui Li, Tao Sun, Lixin Guo, Jun Zhao, Bifa Fan) declare no other conflict of interest and have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study will be performed in accordance with the principles stated in the Declaration of Helsinki of 1964 and its later amendments. Ethical approval from leading hospitals was obtained from the China-Japan Friendship Hospital ethics committee (2024-KY-131) and Beijing Cancer Hospital ethics committee (2024YW107); the collaborating hospitals obtained local approval (Supplementary Tables\u00a0). As a result of all patient data being collected retrospectively, written informed consent from patients was waived by the ethics committee. The results will be published in academic journals and presented at national and international academic conferences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\/Ethical Approval"}},{"value":"Patients and\/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and Public Involvement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent for Publication"}},{"value":"This is version 1.2 of the protocol, dated December 18, 2024. Data collection is ongoing and expected to be completed by September 2025.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial Status"}}]}}